Technology News and Research

RSS

Finer particulate matter (PM1) and risk of cardiovascular disease

A new study published in the journal Environmental Science & Technology Letters reports that particulate matter smaller than a single micron in diameter, called PM1, is strongly linked to the occurrence of cardiovascular disease (CVD). This is thought to be due to its higher surface area to volume ratio.

29 Jan 2020

Portable device to monitor blink reflex receives FDA clearance

EyeStat (blinktbi, Charleston, SC), a portable, lightweight device for measuring the natural blink reflex, received clearance by the U.S. Food and Drug Administration in December 2019.

29 Jan 2020

Finer particulate matter linked to cardiovascular disease risk

In addition to harmful gases such as carbon monoxide, air pollution contains tiny particles that have been linked to health problems, including cardiovascular disease and asthma.

29 Jan 2020

Trelleborg exhibits advanced polymer solutions for healthcare and medical applications at Pharmapack

At Pharmapack, Trelleborg’s healthcare & medical operation exhibits its advanced polymer solutions for healthcare and medical applications.

From Trelleborg AB 29 Jan 2020

Porvair Sciences offers next generation microplate for phospholipid removal

Porvair Sciences announce Microluteä PLR - a new benchmark product for phospholipid removal. The 96-well microplate provides effective removal (>99%) of phospholipids and proteins with higher levels of reproducibility from plasma and serum samples while maintaining maximum recovery of target analytes.

From Chromatrap® - Porvair Sciences Ltd 29 Jan 2020

CSIRO to play role in Australia's bushfire rebuild

CSIRO, Australia's national science agency, has welcomed its role in delivering practical resilience measures in relation to bushfires and climate change, as the country faces continued extreme fire weather in the future.

From CSIRO 29 Jan 2020

New blood sugar tool could one day replace uncomfortable finger-prick test

Researchers have developed a new way to monitor blood sugar levels that could replace the needle-prick method that people with diabetes currently use.

29 Jan 2020

California bike fatalities hit 25-year high

Alongside the surging popularity of bike shares and fitness cycling in California comes a sobering statistic: From 2016 through 2018, more cyclists died in traffic accidents across the state than during any three-year period in the past 25 years.

29 Jan 2020

Study identifies previously unknown toxic by-products potentially present in drinking water

Researchers at John Hopkins University have found that the most common method for disinfecting water can generate toxic by-products.

29 Jan 2020

Kidney paired donation is a safe, effective way to treat patients with incompatible living donors

Recipients of kidney paired donation through a national program, also called kidney exchange, experience equivalent outcomes when compared with all other living donor kidney transplant recipients, according to a recent analysis.

29 Jan 2020

Analysis of Postmortem Microbes using Gas Chromatography

In this interview, Katelynn Perrault, from Chaminade University of Honolulu talks to News-Medical and Life Sciences about her research into using Multidimensional Gas Chromatography to achieve odor profiling of postmortem microbes.

From Pittcon 29 Jan 2020

Nicoya launches groundbreaking new SPR system to accelerate drug discovery

Nicoya, a leading provider of advanced analytical instruments for the biotechnology and pharmaceutical industries, today announced the launch of Alto, the world’s first fully-automated, high-throughput benchtop surface plasmon resonance (SPR) system.

From Nicoya Lifesciences 28 Jan 2020

Avacta demonstrates initial proof-of-concept for TMAC drug conjugates in pre-clinical study

Avacta Group plc, the developer of Affimer biotherapeutics and reagents, is pleased to announce that it has demonstrated initial proof-of-concept for its proprietary new class of drug conjugate, TMAC, in a pre-clinical animal model of cancer.

From Avacta Life Sciences Ltd. 28 Jan 2020

Why new cancer drugs take so long to reach the market

A new analysis of cancer drug development by researchers at the Institute of Cancer Research, London, shows that the more revolutionary a new cancer drug is, the longer it takes to reach patients in the UK’s National Health Service healthcare system. In other words, refinements on earlier drugs or drugs which are more conventional in their effects make it to the marketplace faster

28 Jan 2020

Coronavirus spreads - Australian breakthrough

Novel coronavirus, temporarily named “2019-nCoV”, has affected over 4,600 persons across the world and is spreading at a rapid pace say experts. The World Health Organization and other health organizations have stepped up vigilance to detect and isolate the infection to contain outbreaks.

28 Jan 2020

Successful gene therapy trial in patients with X-linked Chronic Septic Granulomatosis

American and British teams led by Drs Kohn (University of California, Los Angeles), Malech (NIH), Williams (Boston Children's) and Trasher (Great Ormond Street Institute of Child Health) published yesterday in Nature Medicine the conclusive results of a gene therapy trial conducted in the United States and Great Britain in 9 patients with X-linked Chronic Septic Granulomatosis (X-CGD), a rare and severe immune dysfunction. Six of them are free of treatment for complications generated by the disease.

28 Jan 2020

The challenge of new antibiotic discovery

It is important to discover antibiotic drugs and to bring them to clinical use, a task made all the more urgent by the increase in the number of infections that are resistant to existing antibiotics. However, this task is a formidable one.

28 Jan 2020

Weight loss surgery helps reverse respiratory issues in obese patients

Obesity is now considered a global health epidemic, affecting millions of people worldwide. In morbidly obese patients, the extra weight has taken a toll on their overall health, including predisposing them to cardiovascular disease, type 2 diabetes, certain cancers, and respiratory issues. However, breathing issues in obese people may be reversed and relieved, thanks to weight loss surgery.

28 Jan 2020

Study on axolotl's ability to regenerate might help find ways to restore damaged tissue in humans

The type of salamander called axolotl, with its frilly gills and widely spaced eyes, looks like an alien and has other-worldly powers of regeneration. Lose a limb, part of the heart or even a large portion of its brain? No problem: They grow back.

28 Jan 2020

Chan Zuckerberg Initiative announces over $1.3 million to support Global BioImaging

Today, the Chan Zuckerberg Initiative announced over $1.3 million in funding to support Global BioImaging, an international network of bioimaging facilities and communities.

28 Jan 2020